384. Cyclosporine monotherapy is preferred regimen
Tags: KIDNEYS -- Transplantation; IMMUNOSUPPRESSION; CYCLOSPORINE
Related Articles
- Steroid-Free Protocol Avoids Increased Risk of Infection. // Kidney;May/Jun99, Vol. 8 Issue 3, p122
Discusses the abstract of a study entitled `Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy,' by S.A. Birkeland, published in the 1998 journal 'Transplantation.'
- Sirolimus/CsA Reduces Rate of Acute Rejection. // Kidney;May/Jun99, Vol. 8 Issue 3, p121
Discusses the abstract of a study entitled `Immunosuppresive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation,' by B.D. Kaplan, J. Podbielski, K.L. Napoli and others, published in the 1998 journal 'Transplantation.'
- Sirolimus maintenance regimen improves graft survival in kidney transplant recipients. // Formulary;Jul2005, Vol. 40 Issue 7, p232
Reports that kidney transplant recipients on an immunosuppressive regimen of sirolimus plus cyclosporine who had their cyclosporine withdrawn at an early stage had significantly better graft survival than patients who remained on cyclosporine. Improvement in kidney function in the patients in...
- Fine-needle aspiration biopsy in renal transplantation. Häyry, Pekka J. // Kidney International;Jul1989, Vol. 36 Issue 1, p130
Presents a case of a man of Finnish origin admitted to the University of Helshinki hospital for renal transplantation. Transfusion of leukocyte-poor blood from random donors; Comparison of the efficacy of a regimen consisting of azathioprine and steroids versus cyclosporine; Observation of an...
- Cyclosporine absorption profiles in pediatric kidney and liver transplant patients. Kovarik, J. M.; Hoyer, Peter F.; Ettenger, Robert; Punch, Jeffrey; Soergel, Marianne // Pediatric Nephrology;Dec2003, Vol. 18 Issue 12, p1275
Cyclosporine absorption profiling uses either the area under the concentration curve in the first 4 h post dose, AUC(0�4), or the concentration 2 h post dose (C2) to optimize immunosuppression in adult kidney and liver transplantation. We characterized C2 versus AUC(0�4) relationships over...
- Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Chisholm, Marie A.; Lance, Charles E.; Mulloy, Laura L. // American Journal of Health-System Pharmacy;9/1/2005, Vol. 62 Issue 17, p1775
Purpose. Factors associated with adherence to immunosuppressant therapy (IST) in renal transplant recipients were studied. Methods. The Immunosuppressant Therapy Adherence Scale (ITAS) was completed by adult renal transplant recipients in Georgia. Those completing the ITAS were classified as...
- Wide Range of HQL Benefits Seen with Transplant. // Kidney;Sep/Oct98, Vol. 7 Issue 5, p215
Discusses the abstract of a study entitled 'Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression,' by C.F. Shield III, M.M. McGrath and T.F. Goss, published in the 1998 issue of 'Transplantation.'
- 383. Calcineurin avoidance provides comparable 1-year outcomes to cyclosporine. Flechner, S.M.; Goldfarb, D.; Modlin, C. // Kidney;May/Jun2003, Vol. 12 Issue 3, p139
Objective: To determine whether calcineurin inhibitor (CNI) avoidance could result in better kidney function with comparable patient outcomes during the critical first posttransplant year. Methodology: A randomized, prospective trial of calcineurin inhibitor drug avoidance was conducted in 61...
- Optimal Blood Concentration of Cyclosporine Among Iranian Kidney Transplant Recipients. Rostami, Zohreh; Einollahi, Behzad; Teimoori, Mojtaba // Iranian Journal of Kidney Diseases;Oct2012, Vol. 6 Issue 5, p373
Introduction. Clinical information concerning cyclosporine dose reduction in Iranian kidney transplant recipients is limited. There are data in Asian, Caucasian, and Iranian ethnic kidney transplant recipients that recommend the trough level (C0) and 2-hour postdose level (C2) of cyclosporine...
